These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 29374860

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Analysis of DNA methylation alterations in cellfree DNA fraction during colorectal cancer development].
    Molnár KB.
    Magy Onkol; 2020 Mar 17; 64(1):70-72. PubMed ID: 32181765
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
    Bedin C, Enzo MV, Del Bianco P, Pucciarelli S, Nitti D, Agostini M.
    Int J Cancer; 2017 Apr 15; 140(8):1888-1898. PubMed ID: 27943272
    [Abstract] [Full Text] [Related]

  • 8. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M, Moran S, Páez de la Cadena M, Martínez-Zorzano VS, Rodríguez-Berrocal FJ, Rodríguez-Girondo M, Esteller M, Cubiella J, Bujanda L, Castells A, Balaguer F, Jover R, De Chiara L.
    Clin Epigenetics; 2018 Apr 15; 10():53. PubMed ID: 29686738
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update.
    Molnár B, Galamb O, Kalmár A, Barták BK, Nagy ZB, Tóth K, Tulassay Z, Igaz P, Dank M.
    Expert Rev Mol Diagn; 2019 Jun 15; 19(6):477-498. PubMed ID: 31046485
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples.
    Nesic M, Bødker JS, Terp SK, Dybkær K.
    Biomed Res Int; 2021 Jun 15; 2021():5585148. PubMed ID: 34307658
    [Abstract] [Full Text] [Related]

  • 17. Performance of ImproGene cfDNA blood collection tubes for mutation analysis in cancer patients.
    Zhang S, Zhou D, Li S, Bai Y, Huang B, Han J, Xu M, Wang S, Deng G.
    Scand J Clin Lab Invest; 2022 Sep 15; 82(5):378-384. PubMed ID: 35861435
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.